Patents by Inventor Buhan Huang

Buhan Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100278945
    Abstract: The invention is directed to chemical processes of preparing fractions from North American Ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: July 19, 2010
    Publication date: November 4, 2010
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Patent number: 7763290
    Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Grant
    Filed: July 16, 2008
    Date of Patent: July 27, 2010
    Assignee: FX LifeSciences AG
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Publication number: 20080286389
    Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: July 16, 2008
    Publication date: November 20, 2008
    Applicant: fx Life Sciences International GmbH
    Inventors: Jacqueline J. Shan, Peter K.T. Pang, Buhan Huang, Lei Ling
  • Patent number: 7413756
    Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: August 19, 2008
    Assignee: fX Life Sciences International GmbH
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Patent number: 7186423
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: March 6, 2007
    Assignee: fx Life Sciences International GmbH
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Patent number: 7067160
    Abstract: This invention is directed towards processes of making fractions from North American ginseng and to compositions containing these fractions. This invention is also directed towards methods of methods of preparing pharmaceuticals containing these fractions. Additionally, this invention is directed towards methods of stimulating the production of immunoglobins by administering fractions of this invention and also to methods of activating B-lymphocyte proliferation and antibody production by administering fractions of this invention. This invention is also directed towards a method of stimulating the production of IL-16, IL-1, and/or TNF-? in cells by administering a fraction of this invention.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: June 27, 2006
    Assignee: C V Technologies Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Publication number: 20050196471
    Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 8, 2005
    Applicant: C V Technologies Inc.
    Inventors: Jacqueline Shan, Peter Pang, Buhan Huang, Lei Ling
  • Publication number: 20040137087
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 15, 2004
    Applicant: C.V. Technologies, Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Publication number: 20030124207
    Abstract: This invention is directed towards processes of making fractions from North American ginseng and to compositions containing these fractions. This invention is also directed towards methods of methods of preparing pharmaceuticals containing these fractions. Additionally, this invention is directed towards methods of stimulating the production of immunoglobins by administering fractions of this invention and also to methods of activating B-lymphocyte proliferation and antibody production by administering fractions of this invention. This invention is also directed towards a method of stimulating the production of IL-16, IL-1, and/or TNF-&agr; in cells by administering a fraction of this invention.
    Type: Application
    Filed: July 2, 2002
    Publication date: July 3, 2003
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Publication number: 20030077341
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: July 2, 2002
    Publication date: April 24, 2003
    Applicant: C.V. Technologies, Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Patent number: 6432454
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: August 13, 2002
    Assignee: C. V. Technologies, Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling